RAC 3.31% $1.61 race oncology ltd

Ann: Updated Strategy and Investor Presentation, page-224

  1. 392 Posts.
    lightbulb Created with Sketch. 92
    My impression was that apart from the more efficient application, there are so many similarities that any adversity that wasn't obvious in RC110 should not be expected in RC220 either. It's just a more effecient tool that needs to technically go through the hoops as RC110 did.

    The upside of RC220 going into the future has been discussed often here too, the commercial viability and IP protection should theoretically be higher. This has been discussed quite a bit but I'm on my phone so I can't reference.

    I should hope the company is extremely confident. I have been invested for years and would love to see some return on the horizon.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.61
Change
-0.055(3.31%)
Mkt cap ! $273.4M
Open High Low Value Volume
$1.66 $1.68 $1.61 $271.5K 166.3K

Buyers (Bids)

No. Vol. Price($)
1 1996 $1.61
 

Sellers (Offers)

Price($) Vol. No.
$1.68 1305 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.